Charles River Acquires NewLab BioQuality AG
Both Charles River and NewLab provide analytical, molecular biology, virology and microbiology testing services to ensure identity, quality, stability and safety of biopharmaceuticals, and operate in full compliance with current GMP/GLP (Good Laboratory Practice) regulatory guidance. Together, Charles River and NewLab expect to provide the most comprehensive service package in the biopharmaceutical industry at a time when biologic drugs are becoming an increasing proportion of therapeutics in development.
With current operations in the United States, Scotland and Ireland, the transaction will expand Charles River's current biopharmaceutical services footprint by adding two facilities in continental Europe and will further enhance its European and Asian client base.
Organisationen
Weitere News aus dem Ressort Wirtschaft & Finanzen
Holen Sie sich die Analytik- und Labortechnik-Branche in Ihren Posteingang
Ab sofort nichts mehr verpassen: Unser Newsletter für Analytik und Labortechnik bringt Sie jeden Dienstag auf den neuesten Stand. Aktuelle Branchen-News, Produkt-Highlights und Innovationen - kompakt und verständlich in Ihrem Posteingang. Von uns recherchiert, damit Sie es nicht tun müssen.